R&D Partner Content 6th Age-Related Disease Therapeutics Summit Translating Aging Science into a Clinical Reality
R&D Partner Content 7th CNS Drug Delivery Summit Unlocking Safer, More Efficient Delivery to Targeted Brain Regions by Advancing Direct, & Systemic Delivery to the CNS Via TfR1 & Beyond
R&D Partner Content Innovating Disease-Modifying Neurodegenerative Therapies to ... Discovering, Translating & Clinically Advancing Novel Targets
R&D Partner Content 4th LNP Immunogenicity & Toxicity Summit Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
R&D Partner Content Itching for derm progress? We’ve got the cure. Join 120+ peers at the 9th Dermatology Drug Development Summit
R&D Partner Content 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology
News Sleep apnoea drug firm Apnimed files for IPO Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for obstructive sleep apnoea.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
